APA (7th ed.) Citation

Saridogan, T., Akcakanat, A., Zhao, M., Evans, K. W., Yuca, E., Scott, S., . . . Meric-Bernstam, F. (2023). Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific reports, 13(1), 20223-15. https://doi.org/10.1038/s41598-023-46586-y

Chicago Style (17th ed.) Citation

Saridogan, Turcin, et al. "Efficacy of Futibatinib, an Irreversible Fibroblast Growth Factor Receptor Inhibitor, in FGFR-altered Breast Cancer." Scientific Reports 13, no. 1 (2023): 20223-15. https://doi.org/10.1038/s41598-023-46586-y.

MLA (9th ed.) Citation

Saridogan, Turcin, et al. "Efficacy of Futibatinib, an Irreversible Fibroblast Growth Factor Receptor Inhibitor, in FGFR-altered Breast Cancer." Scientific Reports, vol. 13, no. 1, 2023, pp. 20223-15, https://doi.org/10.1038/s41598-023-46586-y.